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Abstract—With the increasing incidence of tuberculosis and 
rated second to HIV-AIDS by the World Health Organisation as 
a leading cause of death from infectious disease and increased 
resistance to drugs currently in use, there is therefore the need 
for alternative sources of drugs for the treatment of this disease. 
Pinus glabra presents as a potential candidate for such drugs 
discovery. Concoctions derived from the plant have been used to 
treat cases of rheumatism, cough, piles and catarrh. Sample 
extraction was performed by soaking the stem samples in ethanol 
for 172 h, which gave reddish-yellow oil after removal of the 
ethanol solvent. The oil was partitioned between 1:1 
water/chloroform mixture. The aqueous layer was further 
partitioned separately with ethyl acetate and hexane. The 
phytochemical screening of the crude ethanol extract revealed 
the presence of alkaloids, saponins, tannins and flavonoids. 
Antimicrobial tests were performed on the crude ethanol extract, 
ethyl acetate and hexane fractions against clinical isolates 
Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa 
and Klebsiella sp. by measurement of zones of inhibition. All test 
samples exhibited significant antimicrobial activity against the 
organisms albeit to different extent. 
Keywords—Phytochemical studies; antimicrobial studies; anti-
Mycobacterium tuberculosis; isolation and extraction; pinus glabra 
I. INTRODUCTION 
This template, You may ask why we need new TB drugs, 
when there are several drugs out there in the market. 
There are three main reasons why we need new TB drugs: 
there is the complexity and toxicity of the current TB drug 
regimens; the issue of TB drug resistance; and the problem of 
the interaction of current TB drugs with antiretroviral drugs 
taken by HIV positive people [1]. 
So what are we looking for in the new drugs? 
1. Shorter and simpler, but still affordable multi drug 
regimens for drug sensitive TB; 
2. Shorter, more effective, less toxic and less expensive 
regimens for drug resistant TB;  
3. Short, simple, easily tolerable and safe regimens for 
latent TB; 
4. Drugs with few drug interactions so they can be safely 
provided to people with people with HIV. 
Mycobacterium tuberculosis of the genus mycobacterium is 
the major cause of tuberculosis, which is the leading cause of 
death after HIV [2]. There was an estimated 8.8 million 
incidence of TB globally in 2010. 
Nigeria has the fourth largest cases of tuberculosis in the 
world with more than 460,000 cases in 2007 [3]. The mortality 
cases of TB in Nigeria have been put at 320 in every 100,000. 
Majority of the peoples of the developing countries of the 
world still rely on traditional medicine derived mainly from 
325
3rd International Conference on African Development Issues (CU-ICADI 2016)
ISSN:2449-075X
Copyright © 2016 by Covenant University Press
  
medicinal plants. Medicinal plants remain important sources 
for finding new active drugs or new therapeutic agents [4]. 
Phytomedicines have shown great promise in the treatment of 
intractable infectious diseases including tuberculosis [5] [6]. 
Pinus glabra has been used to treat chronic rheumatism, 
catarrh and swollen testicles [7]. 
The failure of the Directly Observed Therapy, Shot Course 
Strategy (DOTS), the prevalence of multi drugs resistance 
tuberculosis (MDRTB) and the emergence of extensively drug 
resistant tuberculosis (XDR-TB) it has become necessary to 
look for alternative sources of drugs and the screening of 
herbal plants with anti-mycobacterial effect therefore needs to 
be paid serious attention. 
With these observations in mind, it was decided to extract, 
isolate and characterise the secondary metabolites from the 
stem of Pinus glabra and to determine their anti-microbial 
potential. 
Previous studies on the Pinaceae family have revealed that 
the chemical constituents were mostly terpenoids, flavonoids, 
phenols, steroids, fatty acids and fatty alcohols [8] [9] [10] and 
the extracts were found to possess bioactivities as anti tumour, 
anti-hypertensive and antitussive agents. 
The family were also found to possess antimicrobial 
activity against Bacillus megatherium, Bacillus subtilis, 
Bacillus cereus, Klebsiella pneumoniae, Enterobacter 
aerogenes, Staphylococcus aureus, Mycobacterium smegmatis, 
Proteus vulgaris, Listeria monocytogenes, Pseudomonas 
aeruginosa, Candida albicans, Candida tropicalis and 
Penicillium italicum [11]. 
II. MATERIAL AND METHOD 
Pinus glabra used in this study was harvested from the 
university grounds and authenticated in the biological sciences 
department of the university. 
The sample stem (1000 g) was soaked in ethanol (6.10 L) 
for 168 h. After which time the solution was decanted and 
filtered. The filtrate was distilled on a rotary evaporator to give 
yellow/red oil (189.5 g). The ethanolic extract (50 mL) was 
partitioned between water:chloroform mixture (1:1) in a 
separators funnel. After separation the chloroform fraction (F1) 
was kept and the aqueous layer was further partitioned between 
water and ethyl acetate. 
After separation the ethyl acetate fraction (F2) was kept and 
the aqueous layer was again partitioned between water and n-
hexane. After separation the aqueous layer (F3) and n-hexane 
fraction (F4) was kept for analysis. 
Phytochemical screening was carried out on the crude 
ethanolic extract using standard methods as described by 
Trease and Evans [12]. A summary of the screening result is 
shown in Table 1. 
Bacterial cultures of E. coli, Staphylococcus aureus, 
Klebsiella sp., Pseudomonas aeruginosa were maintained on 
nutrient with broth at 37oC for 24 h prior to testing, used for 
antimicrobial analysis on an agar well diffusion technique. 
Ethanol extract, n-hexane extract and ethyl acetate extract 
at 50 mg/mL was introduced into the wells. Chloramphenicol 
(100 mg/mL) was used as a positive control and 20% nutrient 
agar as negative control. 
The outcomes of the measurements of the zones of 
inhibition for antimicrobial tests are recorded in Table 2. 
III. RESULTS AND DISCUSSION 
The phytochemical screening of Pinus glabra stem revealed 
that crude ethanolic extracts of Pinus glabra stem contained 
flavonoids, alkaloids, tannins, saponins, phenol, cardiac 
glycosides and saponin glycosides at very high intensity while 
anthraquinones were moderately present.  
The antimicrobial potential of crude extract and fractions 
during partitioning were assessed in terms of zone of 
inhibition of bacterial growth. The result antimicrobial 
activities is presented in Table 2.  Activity were studied at 50 
mg/ml concentration against four pathogenic bacterial strains, 
one Gram-positive (Staphylococcus aureus) and three Gram-
negative (Escherichia coli, Klebsiella pneumoniae and 
Pseudomonas aeruginosa). As compared with standard drugs, 
the results revealed that majority of the extracts were sensitive 
while Ethyl acetate extract showed no sensitivity towards E. 
coli.  
 
Table 1. Summary of Phytochemical screening of ethanol 







Cardiac glycosides +++ 
Phenol +++ 
Saponin glycosides  +++ 
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Table 2. Zones of Inhibition 
Test organism Zone of inhibition (mm) 




E. coli  16 - 15 
Staphylococcu
s aureus 
15 10 13 
Pseudomonas 
aeruginosa  




15 10 13 
 
IV. CONCLUSION 
The Phytochemical screening which revealed the presence 
of secondary metabolites and the antimicrobial activities of the 
various fractions against selected bacteria show that Pinus 
glabra is a potential candidate for the treatment of various 
ailments as has been reported for other members of the plant 
family [7]. 
We are therefore working on isolating and characterising 
the individual components of the extract and testing for their 
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